Cite

HARVARD Citation

    Patil, R. et al. (n.d.). 11P PD-L1 profiling of circulating tumour cells is a viable companion diagnostic for checkpoint inhibitor therapy in lung cancer. Annals of oncology. p. . [Online]. 
  
Back to record